Re: No mention of efficacy again...

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10734 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: No mention of efficacy again...

in response to

Re: No mention of efficacy again...

Buckeyes

posted on Mar 29, 2019 04:07PM

Buckeyes, where do you stand?

Do you agree with Bear, that there is a reasonable argument for a $5-$7 billion valuation at this point in time if this is what you are stating?

"$5-$7 billion would be a reasonable offer right now, pre-top-line, with the buying big pharma assuming the risk of BETonMACE failure."